Yazar "Demirkan, Fatih" için listeleme
-
Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
Durak Aras, Beyhan; Işık, Sevgi; Üsküdar Teke, Hava; Aslan, Abdulvahab; Yavaşoğlu, Filiz; Gülbaş, Zafer; Demirkan, Fatih; Özen, Hülya; Çilingir, Oğuz; İnci, Nur Sena; Günden, Gülçin; Bulduk, Tuba; Erzurumluoğlu Gökalp, Ebru; Kocagil, Sinem; Artan, Sevilhan; Akay, Olga Meltem (BioMed Central Ltd, 2021)Background Deletion of 13q14 [del(13q)] is the most common cytogenetic change (50%) in chronic lymphoblastic leukemia (CLL), and it is a good prognostic factor if it is detected as a sole aberration by FISH. However, it ...
